Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05183932 · ClinicalTrials.gov registry record
Surgery Versus Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer
A clinical trial of Non-Small Cell Lung Cancer, sponsored by Washington University School of Medicine.
- Recruiting
- Registry status
- 444
- Enrollment target
- 8
- Study locations
NCT05183932 is a study of Non-Small Cell Lung Cancer that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 444 participants, below the 658-participant average among 449 other Non-Small Cell Lung Cancer trials with a reported enrollment target (33% lower). The trial reports 8 study locations across 8 states.
The verdict
NCT05183932, a study of Non-Small Cell Lung Cancer, is actively recruiting participants, sponsored by Washington University School of Medicine.
- RECRUITING
- Registry status
- 444 participants
- Enrollment target
- 8
- Study locations
Study Summary
The development of stereotactic body radiation therapy (SBRT) for the treatment of stage I non-small cell lung cancer (NSCLC) has inspired a close partnership between thoracic surgery and radiation oncology. In this study, patients with stage I NSCLC will be screened prior to treatment and will be consented after their treatment plan has been determined. Prospectively collected patient-reported outcomes (PROs) will be collected for 3 years or for the duration of the study (whichever is shorter), as will outcomes data.
Conditions Studied
Study Locations (8)
Georgia
- Emory University - Atlanta
Illinois
- Carle Cancer Institute - Urbana
Missouri
- Washington University School of Medicine - St Louis
New York
- Memorial Sloan Kettering - New York
North Carolina
- Duke University - Durham
Ohio
- Cleveland Clinic - Cleveland
Texas
- University of Texas MD Anderson Cancer Center - Houston
Ontario
- University of Toronto - Toronto
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 444 participants |
| Start Date | 2022-07-14 |
| Est. Completion | 2029-01-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05183932
The ClinicalTrials.gov registry entry for NCT05183932 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 444 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 658-participant average among 449 other Non-Small Cell Lung Cancer trials with a reported enrollment target (33% lower). The listed sponsor is Washington University School of Medicine, which has 1,502 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Non-Small Cell Lung Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT05183932 reports 8 study locations spanning 8 distinct geographic areas - top geographies include Georgia, Illinois, Missouri.
Frequently Asked Questions
What is clinical trial NCT05183932 about?
NCT05183932 is a clinical study titled "Surgery Versus Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer". The development of stereotactic body radiation therapy (SBRT) for the treatment of stage I non-small cell lung cancer (NSCLC) has inspired a close partnership between thoracic surgery and radiation oncology. In this study, patients with stage I NSCLC will be screened prior to treatment and will be c...
What is the current status of trial NCT05183932?
This trial is currently recruiting. The enrollment target is 444 participants. The study started on 2022-07-14. Estimated completion is 2029-01-31.
What conditions does trial NCT05183932 study?
This clinical trial studies the following conditions: Non-Small Cell Lung Cancer.
Who is sponsoring clinical trial NCT05183932?
This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05183932 being conducted?
This trial has 8 study locations across Georgia, Illinois, Missouri, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Non-Small Cell Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study to Evaluate Safety, Efficacy, and Pharmacokinetics in Participants With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
RECRUITING · Phase 3
-
A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
RECRUITING · Phase 1
-
Neoadjuvant Dupilumab and Cemiplimab in Patients With Early-stage Resectable NSCLC
RECRUITING · Phase 1
-
A Study Investigating BG-60366 in Adults With Epidermal Growth Factor Receptor (EGFR)-Mutant Non-Small Cell Lung Cancer
RECRUITING · Phase 1
-
Clinical Trial Evaluating the Safety, Tolerability and Preliminary Efficacy of BNT116 Alone and in Combinations in Patients With Advanced Non-small Cell Lung Cancer
RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.